Field performance of three Ebola rapid diagnostic tests used during the 2018-20 outbreak in the eastern Democratic Republic of the Congo: a retrospective, multicentre observational study.

[1]  William Rodriguez,et al.  Comparative performance study of three Ebola rapid diagnostic tests in Guinea , 2020, BMC Infectious Diseases.

[2]  J. Kuhn,et al.  Ebola virus disease , 2020, Nature Reviews Disease Primers.

[3]  Michael Proschan,et al.  A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics. , 2019, The New England journal of medicine.

[4]  J. Inungu,et al.  Recurrent Ebolavirus disease in the Democratic Republic of Congo: update and challenges , 2019, AIMS public health.

[5]  A. Takada,et al.  Clinical Evaluation of QuickNaviTM-Ebola in the 2018 Outbreak of Ebola Virus Disease in the Democratic Republic of the Congo , 2019, Viruses.

[6]  P. Formenty,et al.  Enhancing laboratory capacity during Ebola virus disease (EVD) heightened surveillance in Liberia: lessons learned and recommendations , 2019, The Pan African medical journal.

[7]  G. Ippolito,et al.  Recent advances in the development and evaluation of molecular diagnostics for Ebola virus disease , 2019, Expert review of molecular diagnostics.

[8]  M. Perkins,et al.  Comparative performance of four rapid Ebola antigen-detection lateral flow immunoassays during the 2014-2016 Ebola epidemic in West Africa , 2019, PloS one.

[9]  S. Günther,et al.  Ebola virus disease , 2019, The Lancet.

[10]  Devy M. Emperador,et al.  Diagnostics for filovirus detection: impact of recent outbreaks on the diagnostic landscape , 2019, BMJ Global Health.

[11]  S. Ahuka-Mundeke,et al.  Where are the Ebola diagnostics from last time? , 2019, Nature.

[12]  D. Srikrishna,et al.  Deploying RDTs in the DRC Ebola outbreak , 2018, The Lancet.

[13]  G. Ippolito,et al.  EBOLA Ag K-SeT rapid test: field evaluation in Sierra Leone. , 2017, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[14]  A. Takada,et al.  Development of an Immunochromatography Assay (QuickNavi-Ebola) to Detect Multiple Species of Ebolaviruses. , 2016, The Journal of infectious diseases.

[15]  M. J. Broadhurst,et al.  Diagnosis of Ebola Virus Disease: Past, Present, and Future , 2016, Clinical Microbiology Reviews.

[16]  M. J. Broadhurst,et al.  Performance of the GeneXpert Ebola Assay for Diagnosis of Ebola Virus Disease in Sierra Leone: A Field Evaluation Study , 2016, PLoS medicine.

[17]  A. C. Carrillo,et al.  Correction: Analytical Performance Characteristics of the Cepheid GeneXpert Ebola Assay for the Detection of Ebola Virus , 2015, PloS one.

[18]  M. Perkins,et al.  The Case for Improved Diagnostic Tools to Control Ebola Virus Disease in West Africa and How to Get There , 2015, PLoS neglected tropical diseases.

[19]  M. Perkins,et al.  What Ebola tells us about outbreak diagnostic readiness , 2015, Nature Biotechnology.

[20]  H. Sikes,et al.  Addressing Barriers to the Development and Adoption of Rapid Diagnostic Tests in Global Health , 2015, Nanobiomedicine.